Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zebin Zhu

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Scientific Reports|May 5, 2019
Author Correction: A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisShanzhou Huang, Chengjun Sun, Yuchen Hou, et al.
Scientific Reports|May 18, 2018
A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisShanzhou Huang, Chengjun Sun, Yuchen Hou, et al.
Journal of Visualized Experiments : Jove|December 21, 2020
Avoiding Ischemia Reperfusion Injury in Liver TransplantationYixi Zhang, Changjun Huang, Weiqiang Ju, et al.
Gut|November 5, 2025
Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort studyJun Fang, Siyi Zhong, Tielong Wang, et al.
Epigenomics|February 1, 2019
Comprehensive and combined omics analysis reveals factors of ischemia-reperfusion injury in liver transplantationShanzhou Huang, Weiqiang Ju, Zebin Zhu, et al.
Frontiers in Medicine|January 11, 2020
The First Case of Ischemia-Free Kidney Transplantation in HumansXiaoshun He, Guodong Chen, Zebin Zhu, et al.
Annals of Transplantation|April 21, 2018
Does Ischemia Free Liver Procurement Under Normothermic Perfusion Benefit the Outcome of Liver Transplantation?Qiang Zhao, Shanzhou Huang, Dongping Wang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 17, 2020
Association of Perfusion Characteristics and Posttransplant Liver Function in Ischemia-Free Liver TransplantationZhiheng Zhang, Yunhua Tang, Qiang Zhao, et al.
Clinical and Translational Medicine|April 27, 2022
Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantationZhiyong Guo, Jinghong Xu, Shanzhou Huang, et al.
BMJ Open|May 8, 2020
Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver diseaseChangjun Huang, Shanzhou Huang, Yunhua Tang, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Scientific Reports|May 5, 2019
Author Correction: A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisShanzhou Huang, Chengjun Sun, Yuchen Hou, et al.
Scientific Reports|May 18, 2018
A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisShanzhou Huang, Chengjun Sun, Yuchen Hou, et al.
Journal of Visualized Experiments : Jove|December 21, 2020
Avoiding Ischemia Reperfusion Injury in Liver TransplantationYixi Zhang, Changjun Huang, Weiqiang Ju, et al.
Gut|November 5, 2025
Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort studyJun Fang, Siyi Zhong, Tielong Wang, et al.
Epigenomics|February 1, 2019
Comprehensive and combined omics analysis reveals factors of ischemia-reperfusion injury in liver transplantationShanzhou Huang, Weiqiang Ju, Zebin Zhu, et al.
Frontiers in Medicine|January 11, 2020
The First Case of Ischemia-Free Kidney Transplantation in HumansXiaoshun He, Guodong Chen, Zebin Zhu, et al.
Annals of Transplantation|April 21, 2018
Does Ischemia Free Liver Procurement Under Normothermic Perfusion Benefit the Outcome of Liver Transplantation?Qiang Zhao, Shanzhou Huang, Dongping Wang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 17, 2020
Association of Perfusion Characteristics and Posttransplant Liver Function in Ischemia-Free Liver TransplantationZhiheng Zhang, Yunhua Tang, Qiang Zhao, et al.
Clinical and Translational Medicine|April 27, 2022
Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantationZhiyong Guo, Jinghong Xu, Shanzhou Huang, et al.
BMJ Open|May 8, 2020
Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver diseaseChangjun Huang, Shanzhou Huang, Yunhua Tang, et al.
Pageof 7